000			01611 a2200445 4500
005			20250516081534.0
264		0	_c20120426
008			201204s 0 0 eng d
022			_a1662-2944
024	7		_a10.1159/000335153 _2doi
040			_aNLM _beng _cNLM
100	1		_aZecher, Daniel
245	0	0	_aFuture trends in organ transplant recipients--important issues for dermatologists. _h[electronic resource]
260			_bCurrent problems in dermatology _c2012
300			_a71-80 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAbatacept
650	0	4	_aAlefacept
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aBoronic Acids _xtherapeutic use
650	0	4	_aBortezomib
650	0	4	_aCalcineurin Inhibitors
650	0	4	_aForecasting
650	0	4	_aGraft Survival _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xtherapeutic use
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aOrgan Transplantation _xadverse effects
650	0	4	_aPyrazines _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRisk Assessment _xmethods
650	0	4	_aRituximab
650	0	4	_aSkin Neoplasms _xetiology
700	1		_aSteiger, Jürg
773	0		_tCurrent problems in dermatology _gvol. 43 _gp. 71-80
856	4	0	_uhttps://doi.org/10.1159/000335153 _zAvailable from publisher's website
999			_c21585331 _d21585331